The increasing urbanization in Africa, paralleled by inadequate environmental sanitation, significantly contributes to the proliferation of Aedes mosquitoes, which transmit many arboviruses, including dengue virus (DENV) and Chikungunya virus (CHIKV).

In  2023, a total of 70 223 cases of dengue and 753 deaths have been reported from 15 African countries. Burkina Faso continues to be the country most impacted, accounting for 85% of reported cases and 91% of recorded fatalities. In 2023 Mali experienced simultaneous outbreaks of dengue and chikungunya infections.

The VectorEnd project promotes  an integrated vector control approach to mitigate the burden of dengue and chikungunya, in urban areas of Burkina Faso, Mali, and Tanzania with high incidences of these diseases.

This initiative marks the first comprehensive trial in African urban settings to assess the combined effect of mass trapping, larval source management, and community engagement on controlling Aedes mosquitoes and the diseases they transmit.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

HORIZON-JU-GH-EDCTP3-2024-01-06-two-stage Call successful submission

A consortium composed by University of Sciences, Technologies and Techniques of Bamako (USTTB, Mali), Ministry of Health of Burkina Faso,  University of Bordeaux (France), and Fondazione Bruno Kessler (FBK, Italy)

Eleventh EDCTP Forum

R-evoWW took part to the Eleventh EDCTP Forum in the Palais des Congrès de Paris in Paris (France) from 7th to 10th November 2023. This Forum marked EDCTP’s 20th Anniversary and the

NeuroSolve project obtained the Clinical Trial Ethical Approval in Zambia too!

After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.